# The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

> **NCT03679143** · PHASE1 · COMPLETED · sponsor: **Guangdong Zhongsheng Pharmaceutical Co., Ltd.** · enrollment: 103 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** ZSP1273 100 mg
- **DRUG:** Placebo 100 mg
- **DRUG:** ZSP1273 200 mg
- **DRUG:** Placebo 200 mg
- **DRUG:** ZSP1273 400 mg
- **DRUG:** Placebo 400 mg
- **DRUG:** ZSP1273 600 mg
- **DRUG:** Placebo 600 mg
- **DRUG:** ZSP1273 900 mg
- **DRUG:** Placebo 900 mg
- **DRUG:** ZSP1273 1200 mg
- **DRUG:** Placebo 1200 mg
- **DRUG:** ZSP1273
- **DRUG:** Placebo
- **DRUG:** ZSP1273 Low Dose
- **DRUG:** Placebo
- **DRUG:** ZSP1273 Median Dose
- **DRUG:** Placebo
- **DRUG:** ZSP1273 High Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03679143
- **Lead sponsor:** Guangdong Zhongsheng Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-20
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-04-26
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679143, "The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03679143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*